This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks.com featured highlights include: Gartner, East West Bancorp, Landstar System, HCA Healthcare and KLA Corp
by Zacks Equity Research
Zacks.com featured highlights include: Gartner, East West Bancorp, Landstar System, HCA Healthcare and KLA Corp
Encompass Health (EHC) Buys Frontier, Boosts Home Health Services
by Zacks Equity Research
Encompass Health (EHC) completes the purchase of Frontier, which reflects its efforts to offer enhanced care across several states.
5 GARP Stocks to Scoop Up for Maximum Returns
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Here's Why You Should Retain Acadia Healthcare (ACHC) Stock
by Zacks Equity Research
Acadia Healthcare (ACHC) is gaining from rise in revenues, several acquisitions and joint ventures as well as robust cash flows.
Cooper Companies (COO) Unit's Ortho-K Lens Receives CE Mark
by Zacks Equity Research
Cooper Companies' (COO) unit CooperVision's latest orthokeratology contact lens becomes the latest myopia control product to gain European approval.
Here's Why You Should Retain PerkinElmer (PKI) Stock Now
by Zacks Equity Research
PerkinElmer (PKI) continues to gain traction on a solid product portfolio and improving margins. However, forex woes linger.
Cooper Companies (COO) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Cooper Companies' (COO) fiscal second-quarter results are likely to reflect segmental strength.
Change Healthcare (CHNG) Q4 Earnings & Revenues Top Estimates
by Zacks Equity Research
Change Healthcare's (CHNG) fiscal fourth-quarter results benefit from solid performance in the Network Solutions segment.
Encompass Health (EHC) Gains on Strong Revenues & Cash Flows
by Zacks Equity Research
Encompass Health (EHC) set to benefit on the back of consistent top-line growth, robust 2021 business outlook and strong liquidity stand.
HCA Healthcare (HCA) Ties Up for Accelerating Digital Processes
by Zacks Equity Research
HCA Healthcare (HCA) forms alliance with Google Cloud with an aim to speed up digital transformation of the former, resulting in enhanced clinical and operational processes.
Here's Why You Should Retain Patterson Companies (PDCO) Stock
by Zacks Equity Research
Patterson Companies (PDCO) continues to benefit from strength in Animal Health business and robust product portfolio. However, high debt level remains a woe.
5 Solid Reasons Why The Joint (JYNT) Looks Attractive Now
by Zacks Equity Research
The Joint Corp. 's (JYNT) resilient business model along with its long-term expansion plans makes it a perfect fit for your investment portfolio.
HCA Healthcare (HCA) to Rebrand Certain Units in Florida
by Zacks Equity Research
HCA Healthcare (HCA) to adopt the HCA Florida Healthcare brand to enhance its appeal and solidify its presence.
Canopy Growth (CGC) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Continued robust product demand is expected to have significantly contributed to Canopy Growth's (CGC) top line in the fiscal fourth quarter.
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
by Zacks Equity Research
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, segmental weakness is a woe.
Share Gain in Core Markets to Aid Medtronic (MDT) Q4 Earnings
by Zacks Equity Research
Growing momentum in capital equipment purchases might have aided Medtronic (MDT) Q4 earnings.
Here's Why You Should Retain Ecolab (ECL) Stock Right Now
by Zacks Equity Research
Ecolab (ECL) continues to gain traction for a solid product portfolio and cost-efficiency program. However, segmental weakness remains a woe.
Veeva Systems' (VEEV) Cloud Offerings Aid Drug Development
by Zacks Equity Research
Veeva Systems' (VEEV) Cloud applications help in simplifying and accelerating drug development on an industry-wide basis.
Veeva Systems (VEEV) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Veeva Systems' (VEEV) fiscal first-quarter results are likely to reflect solid show by its segments and robust product portfolio.
LHC Group (LHCG) Forays Into Tucson Market With New Buyout
by Zacks Equity Research
LHC Group (LHCG) agrees to buy two Casa de la Luz provider locations to expand its hospice service in the Tucson market.
Here's Why You Should Invest in Integer Holdings (ITGR) Stock
by Zacks Equity Research
Integer Holdings (ITGR) continues to gain traction from portfolio management.
Tenet Healthcare (THC) Offers Senior Notes Worth $1.4 B
by Zacks Equity Research
Tenet Healthcare (THC) exhibits prudence by issuing notes to procure funds and pay down its existing debt.
If You Invested $1000 in HCA Holdings 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
PerkinElmer (PKI) to Boost Immunodiagnostics Unit With Buyout
by Zacks Equity Research
PerkinElmer (PKI) enters into an agreement to acquire IDS, which will enable the former to grow its overall Diagnostics business, particularly its immunodiagnostics unit.
STERIS (STE) Q4 Earnings Fall Shy of Estimates, FY22 View Up
by Zacks Equity Research
STERIS' (STE) fourth-quarter 2021 revenues improved year over year on robust growth across three segments.